Correlation Between Telesis Bio and Lucid Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telesis Bio and Lucid Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telesis Bio and Lucid Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telesis Bio and Lucid Diagnostics, you can compare the effects of market volatilities on Telesis Bio and Lucid Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telesis Bio with a short position of Lucid Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telesis Bio and Lucid Diagnostics.

Diversification Opportunities for Telesis Bio and Lucid Diagnostics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Telesis and Lucid is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Telesis Bio and Lucid Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lucid Diagnostics and Telesis Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telesis Bio are associated (or correlated) with Lucid Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lucid Diagnostics has no effect on the direction of Telesis Bio i.e., Telesis Bio and Lucid Diagnostics go up and down completely randomly.

Pair Corralation between Telesis Bio and Lucid Diagnostics

Given the investment horizon of 90 days Telesis Bio is expected to generate 2.77 times more return on investment than Lucid Diagnostics. However, Telesis Bio is 2.77 times more volatile than Lucid Diagnostics. It trades about 0.01 of its potential returns per unit of risk. Lucid Diagnostics is currently generating about -0.01 per unit of risk. If you would invest  2,034  in Telesis Bio on August 28, 2024 and sell it today you would lose (1,736) from holding Telesis Bio or give up 85.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy92.73%
ValuesDaily Returns

Telesis Bio  vs.  Lucid Diagnostics

 Performance 
       Timeline  
Telesis Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Telesis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady forward indicators, Telesis Bio displayed solid returns over the last few months and may actually be approaching a breakup point.
Lucid Diagnostics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lucid Diagnostics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Lucid Diagnostics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Telesis Bio and Lucid Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telesis Bio and Lucid Diagnostics

The main advantage of trading using opposite Telesis Bio and Lucid Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telesis Bio position performs unexpectedly, Lucid Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lucid Diagnostics will offset losses from the drop in Lucid Diagnostics' long position.
The idea behind Telesis Bio and Lucid Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance